Increased risk for renal cell carcinoma in end stage renal disease – a population-based case-control study

John Åkerlunda Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenCorrespondence[email protected]
View further author information

Erik Holmbergb Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenView further author information

Per Lindbladc Department of Urology, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, SwedenView further author information

Maria Stendahld Swedish Renal Registry, Department of Internal Medicine, Ryhov Regional Hospital, Jönköping, SwedenView further author information

Börje Ljungberge Department of Surgical and Perioperative Sciences, Umeå University, Umeå, SwedenView further author information

Andreas Thorstensonf Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;g Uroclinic, Department of Urology at Sophiahemmet, Stockholm, SwedenView further author information

Sven Lundstama Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;b Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenView further author information

show all

Increased risk for renal cell carcinoma in end stage renal disease – a population-based case-control study

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Increased risk for renal cell carcinoma in end stage renal disease – a population-based case-control study

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date